论文部分内容阅读
异名 Eprex 药效分类唾液糖蛋白激素开发单位 (瑞士)Cilag(Johnson & Johns0n) 上市厂商 (瑞士)Cilag(Johnson & Johnson)1988年上市 Epoetin(重组人体红细胞生成素)是唾液糖蛋白激素,从免疫学,生物学角度看,为内源性化合物。本品有增加红细胞生成的作用,作用与剂量成比例,已明确epoetin有治疗慢性肾衰竭贫血的功效,几乎增加所有病人的红细胞压积和血红蛋白水平,且增强生命活力。药效学 Epoetin刺激红血球原始细胞分裂和分化,并与剂量成比例,随着网状细胞计数的增加提高红细胞压积和血红蛋白水
Synonyms Eprex Pharmacopoeia Category Cilag (Johnson & Johnson) Cilag (Johnson & Johnson) Listed in 1988 Epoetin (recombinant human erythropoietin) is a salivary glycoprotein hormone derived from Immunology, biology point of view, for the endogenous compounds. This product has the role of increasing erythropoiesis, the role and dose proportional, it has been clear that epoetin has the effect of treating anemia of chronic renal failure, almost all patients with increased hematocrit and hemoglobin levels, and enhance vitality. Pharmacodynamics Epoetin stimulates red cell blast cell division and differentiation and is dose-proportional, increasing hematocrit and hemoglobin water as reticulocyte counts increase